NCT05672160View on ClinicalTrials.gov

Overal Survival After TAVI According to Sarcopenia

CompletedOBSERVATIONAL

Enrollment

930

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

January 1, 2023

Study Completion Date

January 2, 2023

Conditions

SarcopeniaAortic Valve Stenosis

Interventions

DIAGNOSTIC_TEST

CT evaluated sarcopenia

At L3 level of CT scan we will measure the area and density of muscles and fat tissue. We devided the patients to sarcopenia and non-sarcopenia groups according to these values.

Trial Locations (1)

73961

AGELTrinecPodlesi, Třinec

All Listed Sponsors

lead

Nemocnice AGEL Trinec-Podlesi a.s.

OTHER

NCT05672160 - Overal Survival After TAVI According to Sarcopenia | Biotech Hunter | Biotech Hunter